Publicis Selling Solutions Launches New SFA Sidekick(TM), a Web-Based Collaborative...

* Reuters is not responsible for the content in this press release.

Tue Jan 22, 2008 9:15am EST

Publicis Selling Solutions Launches New SFA Sidekick(TM), a Web-Based Collaborative Contact Management Tool

LAWRENCEVILLE, N.J.--(Business Wire)--Publicis Selling Solutions, a leading provider of sales teams and
support services for biopharma, has developed SFA Sidekick(TM), a
web-based target management tool. SFA Sidekick(TM) allows field sales
representatives and home office staff to make prescriber profile and
call plan changes more easily and efficiently. Publicis Selling
Solutions is a Publicis Healthcare Communications Group company.

   SFA Sidekick(TM) offers sales representatives, sales managers, and
home office operations staff a unique, collaborative tool in which
each stakeholder has input into their territory changes. SFA
Sidekick(TM) is customized to incorporate each client's specific
business rules so that sales representatives are immediately aware of
the impact of any recommended changes. The web-based interface allows
for "anytime/anywhere" access where all stakeholders see one common
view of the planned changes along with an intuitive approval workflow.
As a web-based tool, SFA Sidekick(TM) also conveniently integrates
with all SFA systems, regardless of the platform being used.

   "SFA Sidekick(TM) can turn these routine, large-scale sales force
automation (SFA) edits from a painful process into one that is
infinitely easier and more efficient," states Rick Keefer, COO of
Publicis Selling Solutions Group. "When ongoing, global changes are
made within a company's SFA system, it is filled with problems and
requires a high level of project management and costly report
customization. SFA Sidekick(TM) mirrors the information in the sales
representatives SFA system. This allows changes to take place in a
'safe' environment that is flexible enough to incorporate
collaboration from the sales managers and the home office while
providing online reports to support the decision making process."

   Reckitt Benckiser Pharmaceuticals, a client of Publicis Selling
Solutions, is using the SFA Sidekick(TM) target management tool to
enable field representatives to organize their selling strategies to
targeted physicians on a quarterly basis. "SFA Sidekick(TM) has made a
huge difference in our ability to make call plan execution changes
easily and efficiently," states Brad Ashby, Director, Business
Analytics, Reckitt Benckiser Pharmaceuticals. "This tool has truly
taken the pain out of large scale periodic updates to our
representatives' universe of targets."

   For more information, please contact Susan Johnson at (609)
896-4771 or visit our website at www.psellingsolutions.com.

   About Publicis Selling Solutions

   Publicis Selling Solutions provides sales teams and support
services to pharmaceutical and biotech companies nationwide. The
industry's most experienced biopharma sales professionals, the company
offers a comprehensive range of sales teams, including specialty,
biotech, hospital, primary care, customer service, and blended sales
forces. Additionally, it provides clinical health educators, managed
markets account directors, and vacant territory management. The
organization is part of the Publicis Healthcare Communications Group
network. Telephone: (609) 896-4700. Website: www.psellingsolutions.com

   About Publicis Selling Solutions Group

   Publicis Selling Solutions Group offers a comprehensive range of
sales and marketing services for pharmaceutical and biotech companies.
Through its companies, which include Publicis Selling Solutions,
Arista Marketing Associates, Pharmagistics, and Total Learning
Concepts, the organization delivers messages to all touch-points on
the healthcare continuum from healthcare professionals and managed
markets to patients and caregivers. The group's range of services
includes field sales teams and support services, recruiting, sales
training and content development, inside sales teams, peer influence,
sample compliance, and fulfillment. Publicis Selling Solutions Group
is a Publicis Healthcare Communications Group company. Websites:
www.psellingsolutions.com, www.aristamktg.com, www.pharmagistics.com,
www.tlconline.com

   About Publicis Healthcare Communications Group (PHCG)

   PHCG, a member of Publicis Groupe SA, is one of the largest
healthcare communications groups in the world with over 2,700
employees located in 10 countries. Worldwide healthcare services
include advertising, medical education, sales and marketing, and
medical and scientific affairs. PHCG offers its clients a strategic
partnership, a strong focus on ensuring value for their marketing
spend, and exceptional performance on their assignments. Website:
www.publicishealthcare.com

   About Publicis Groupe

   Publicis Groupe (Euronext Paris: FR0000130577) is the world's
fourth largest communications group. In addition, it is ranked as the
world's second largest media counsel and buying group, and is a global
leader in digital and healthcare communications. With activities
spanning 104 countries on five continents, the Groupe employs
approximately 44,000 professionals.

   The Groupe offers local and international clients a complete range
of communication services, from advertising, through three autonomous
global advertising networks, Leo Burnett, Publicis, Saatchi & Saatchi
and two multi-hub networks, Fallon and 49%-owned Bartle Bogle Hegarty;
to media consultancy and buying, through two worldwide networks,
Starcom MediaVest Group and ZenithOptimedia; interactive and digital
marketing led by Digitas; Specialized Agencies and Marketing Services
(SAMS) offering healthcare communications, corporate and financial
communications, public relations, CRM and direct marketing, event
communications, sports marketing and multicultural communications. Web
site: www.publicisgroupe.com

Publicis Selling Solutions Group
Betsy Lane, 609-896-4704
Vice President, Marketing
BLane@psellingsolutions.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.